Feb 23, 2023 08:00AM
Jan 9, 2023 07:30AM
Nov 28, 2022 09:00AM
Aug 12, 2021 09:00AM
Aug 2, 2021 07:00AM
Jul 22, 2021 09:00AM
Jun 3, 2021 07:00AM Innovation Pharma Completes Enrollment in Phase 2 Clinical Trial for COVID-19
May 27, 2021 10:00AM
May 13, 2021 08:00AM
Apr 28, 2021 08:00AM
Apr 14, 2021 09:30AM
Apr 7, 2021 09:30AM
Apr 5, 2021 07:30AM
Mar 10, 2021 07:30AM Innovation Pharma’s COVID-19 Drug Candidate Brilacidin Ranked in Top Three Percent of Compounds Predicted to Be Most Effective Against SARS-CoV-2
Mar 5, 2021 11:31AM
Mar 2, 2021 09:00AM
Feb 26, 2021 09:00AM
Jan 29, 2021 09:15AM
Jan 14, 2021 07:30AM
Dec 21, 2020 07:00AM
Nov 30, 2020 09:00AM Innovation Pharmaceuticals COVID-19 Clinical Trial to Support Additional Development of Brilacidin as a “Pan-Coronavirus” Therapeutic
Nov 16, 2020 09:00AM
Nov 2, 2020 09:25AM
Oct 30, 2020 07:30AM
Oct 2, 2020 10:00AM
Sep 15, 2020 09:00AM
Sep 8, 2020 10:00AM
Aug 26, 2020 09:30AM Dr. William F. DeGrado, a Discoverer of Brilacidin, Joins Innovation Pharmaceuticals as Scientific Advisor
Aug 24, 2020 08:00AM
Aug 4, 2020 08:00AM
Jul 22, 2020 08:00AM
Jul 20, 2020 07:30AM
Jul 13, 2020 08:00AM
Jul 7, 2020 08:00AM
Jun 17, 2020 07:34AM Innovation Pharmaceuticals (IPIX) Reports Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
Jun 17, 2020 07:30AM
Jun 11, 2020 07:30AM
May 26, 2020 08:08AM
May 26, 2020 08:00AM
May 19, 2020 07:33AM
May 19, 2020 07:30AM
May 5, 2020 09:30AM Inhibitory Effect of Innovation Pharmaceuticals’ Brilacidin on SARS-CoV-2 (COVID-19) in Primary Human Immune Cells to be Studied at Leading Public Health Research Institute
Apr 27, 2020 09:30AM
Apr 20, 2020 09:00AM
Apr 1, 2020 08:21AM
Mar 17, 2020 07:30AM
Mar 12, 2020 08:00AM
Mar 10, 2020 08:20AM
Mar 9, 2020 08:00AM Innovation Pharmaceuticals Brilacidin Received by U.S. Regional Biocontainment Laboratory; Testing Against Coronavirus (COVID-19)
Mar 6, 2020 09:17AM

324,764 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All